A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of Michigan Rogel Cancer Center
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
University of Nebraska
Massachusetts General Hospital
St. Petersburg State Pavlov Medical University
City of Hope Medical Center
City of Hope Medical Center
Roswell Park Cancer Institute
University of Liege
University of Nebraska
University of Nebraska
First Affiliated Hospital of Zhejiang University
Memorial Sloan Kettering Cancer Center
Mesoblast, Ltd.
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Regimmune Corporation
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Rochester
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)